AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing targeted oligonucleotide therapies for functional cure of chronic ...
WASHINGTON — The Trump administration on Tuesday adopted its vaccine advisory committee’s recommendation to end the ...
A Centers for Disease Control and Prevention committee voted to eliminate a recommendation that all newborn babies receive a vaccine against hepatitis B, ending a policy that has been in place since ...
The Arkansas Department of Health is examining its "updated immunization policy," but does not expect any change to school ...
The U.S. Centers for Disease Control and Prevention officially abandoned universal hepatitis B vaccination for newborns on ...
The CDC's move follows a vote from Health Secretary Robert F. Kennedy Jr.'s vaccine advisory panel that entails a major ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio ISA Pharmaceuticals announced that the ...
On Dec. 5, a federal vaccine advisory panel voted to change the long-standing recommendation that all newborns receive a dose ...
A major study validates the GOLDEN model as an accurate tool for predicting HBsAg loss in interferon-treated chronic ...
So far, no infections have been reported among the patients, the hospital said. Hundreds of patients at Salem Hospital in Massachusetts were possibly exposed to hepatitis B, hepatitis C and HIV, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results